Qsymia
NDC 62541-201, phentermine and topiramate, capsule, extended release, from Vivus LLC.
- Product NDC
- 62541-201
- Status
- Listed
- Labeler
- Vivus LLC
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022580
- DEA schedule
- CIV
curl https://api.healthcare.dev/v1/drugs/ndc/62541-201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PHENTERMINE HYDROCHLORIDE3.75 mg/1
- TOPIRAMATE23 mg/1
Pharmacologic classes
Appetite Suppression [PE]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Increased Sympathetic Activity [PE]; Sympathomimetic Amine Anorectic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62541-201-14 | 62541020114 | 14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-201-14) |
| 62541-201-30 | 62541020130 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-201-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/40dd5602-53da-45ac-bb4b-15789aba40f9
Use it
Look up 62541-201 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62541-201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62541-201. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.